摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-nitro-N-[2-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-4-yl)piperazin-1-yl]-2-[4-(trifluoromethyl)phenyl]ethyl]benzenesulfonamide

中文名称
——
中文别名
——
英文名称
4-nitro-N-[2-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-4-yl)piperazin-1-yl]-2-[4-(trifluoromethyl)phenyl]ethyl]benzenesulfonamide
英文别名
——
4-nitro-N-[2-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-4-yl)piperazin-1-yl]-2-[4-(trifluoromethyl)phenyl]ethyl]benzenesulfonamide化学式
CAS
——
化学式
C27H29F3N6O4S
mdl
——
分子量
590.6
InChiKey
YLTYUNMFXXLQTK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    41
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    132
  • 氢给体数:
    2
  • 氢受体数:
    12

文献信息

  • [EN] NOVEL HETEROCYCLIC DERIVATIVES AS MODULATORS OF KINASE ACTIVITY<br/>[FR] NOUVEAUX DÉRIVÉS HÉTÉROCYCLIQUES COMME MODULATEURS DE L'ACTIVITÉ KINASE
    申请人:MERCK PATENT GMBH
    公开号:WO2014078637A1
    公开(公告)日:2014-05-22
    The invention provides novel imidazol-piperidinyl derivatives of the formula (I) in which R1, R2, W, X1, X2, X3, X4 and n have the meanings indicated in formula (I), and their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
    该发明提供了公式(I)中的新型咪唑-哌啶生物,其中R1、R2、W、X1、X2、X3、X4和n具有公式(I)中所示的含义,并且它们的制造和用于治疗高增殖性疾病,如癌症。
  • Novel Heterocyclic Derivatives as Modulators of Kinase Activity
    申请人:LAN Ruoxi
    公开号:US20150274750A1
    公开(公告)日:2015-10-01
    The invention provides novel imidazol-piperidinyl derivatives of the formula (I) in which R 1 , R 2 , W, X 1 , X 2 , X 3 , X 4 and n have the meanings indicated in formula I, and their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
    本发明提供了公式(I)的新型咪唑-哌啶生物,其中R1,R2,W,X1,X2,X3,X4和n具有公式I中所示的含义,并且其制备和用于治疗增生性疾病,如癌症。
  • Heterocyclic derivatives as modulators of kinase activity
    申请人:Merck Patent GmbH
    公开号:US10287300B2
    公开(公告)日:2019-05-14
    The invention provides novel imidazol-piperidinyl derivatives of the formula (I) in which R1, R2, W, X1, X2, X3, X4 and n have the meanings indicated in formula I, and their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
    本发明提供了式 (I) 的新型咪唑-哌啶生物 其中 R1、R2、W、X1、X2、X3、X4 和 n 具有式 I 所示的含义,以及它们的制造和用于治疗过度增殖性疾病(如癌症)的用途。
  • NOVEL HETEROCYCLIC DERIVATIVES AS MODULATORS OF KINASE ACTIVITY
    申请人:Merck Patent GmbH
    公开号:EP2920178A1
    公开(公告)日:2015-09-23
  • NOVEL HETEROCYCLIC DERIVATIVES AS MODULATORS OF KINASE ACTIVITY (P70S6 AND AKT)
    申请人:Merck Patent GmbH
    公开号:EP2920178B1
    公开(公告)日:2016-12-21
查看更多